Clear Harbor Asset Management LLC Sells 114 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Clear Harbor Asset Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,497 shares of the healthcare conglomerate’s stock after selling 114 shares during the quarter. Clear Harbor Asset Management LLC’s holdings in UnitedHealth Group were worth $4,473,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. Moneta Group Investment Advisors LLC raised its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares during the period. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter worth about $5,210,004,000. Arrowstreet Capital Limited Partnership increased its position in shares of UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the period. Barclays PLC boosted its position in shares of UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after acquiring an additional 2,058,829 shares during the period. Finally, Morgan Stanley increased its holdings in UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of NYSE UNH traded up $1.60 during mid-day trading on Thursday, hitting $494.70. The stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The business has a 50 day moving average price of $503.10 and a two-hundred day moving average price of $518.61. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $554.70. The firm has a market cap of $456.08 billion, a P/E ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period last year, the firm earned $5.34 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is 31.54%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on UNH shares. Stephens reiterated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Barclays initiated coverage on shares of UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target on the stock. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $579.33.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.